Literature DB >> 24934691

Scientific overview: 2013 BBC plenary symposium on tobacco addiction.

M De Biasi1, I McLaughlin2, E E Perez3, P A Crooks4, L P Dwoskin5, M T Bardo6, P R Pentel7, D Hatsukami8.   

Abstract

Nicotine dependence plays a critical role in addiction to tobacco products, and thus contributes to a variety of devastating tobacco-related diseases (SGR 2014). Annual costs associated with smoking in the US are estimated to be between $289 and $333 billion. Effective interventions for nicotine dependence, especially in smokers, are a critical barrier to the eradication of tobacco-related diseases. This overview highlights research presented at the Plenary Symposium of Behavior, Biology and Chemistry: Translational Research in Addiction Conference (BBC), hosted by the UT Health Science Center San Antonio, on March 9-10, 2013. The Plenary Symposium focused on tobacco addiction, and covered topics ranging from basic science to national policy. As in previous years, the meeting brought together globally-renowned scientists, graduate student recruits, and young scientists from underrepresented populations in Texas and other states with the goal of fostering interest in drug addiction research in young generations.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Nicotine dependence; Nicotine vaccine; Nicotine withdrawal; Nicotinic receptor antagonists; Smoking cessation; Tobacco product regulation

Mesh:

Year:  2014        PMID: 24934691      PMCID: PMC4227301          DOI: 10.1016/j.drugalcdep.2014.05.013

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  110 in total

Review 1.  Structural and functional diversity of native brain neuronal nicotinic receptors.

Authors:  Cecilia Gotti; Francesco Clementi; Alice Fornari; Annalisa Gaimarri; Stefania Guiducci; Irene Manfredi; Milena Moretti; Patrizia Pedrazzi; Luca Pucci; Michele Zoli
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

Review 2.  Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions.

Authors:  L Greenbaum; B Lerer
Journal:  Mol Psychiatry       Date:  2009-06-30       Impact factor: 15.992

3.  AAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessation.

Authors:  Martin J Hicks; Jonathan B Rosenberg; Bishnu P De; Odelya E Pagovich; Colin N Young; Jian-ping Qiu; Stephen M Kaminsky; Neil R Hackett; Stefan Worgall; Kim D Janda; Robin L Davisson; Ronald G Crystal
Journal:  Sci Transl Med       Date:  2012-06-27       Impact factor: 17.956

4.  Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity.

Authors:  Bishnu P De; Odelya E Pagovich; Martin J Hicks; Jonathan B Rosenberg; Amira Y Moreno; Kim D Janda; George F Koob; Stefan Worgall; Stephen M Kaminsky; Dolan Sondhi; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2012-12-21       Impact factor: 5.695

5.  An immunotherapeutic program for the treatment of nicotine addiction: hapten design and synthesis.

Authors:  S Isomura; P Wirsching; K D Janda
Journal:  J Org Chem       Date:  2001-06-15       Impact factor: 4.354

6.  Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.

Authors:  Cecilia Gotti; Milena Moretti; Francesco Clementi; Loredana Riganti; J Michael McIntosh; Allan C Collins; Michael J Marks; Paul Whiteaker
Journal:  Mol Pharmacol       Date:  2005-03-04       Impact factor: 4.436

7.  Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice.

Authors:  Ramiro Salas; Renea Sturm; Jim Boulter; Mariella De Biasi
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

8.  A DNA nanostructure platform for directed assembly of synthetic vaccines.

Authors:  Xiaowei Liu; Yang Xu; Tao Yu; Craig Clifford; Yan Liu; Hao Yan; Yung Chang
Journal:  Nano Lett       Date:  2012-07-06       Impact factor: 11.189

9.  Distinct roles of segregated transmission of the septo-habenular pathway in anxiety and fear.

Authors:  Takashi Yamaguchi; Teruko Danjo; Ira Pastan; Takatoshi Hikida; Shigetada Nakanishi
Journal:  Neuron       Date:  2013-04-18       Impact factor: 17.173

Review 10.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

View more
  4 in total

1.  Rationalization of a nanoparticle-based nicotine nanovaccine as an effective next-generation nicotine vaccine: A focus on hapten localization.

Authors:  Zongmin Zhao; Yun Hu; Theresa Harmon; Paul Pentel; Marion Ehrich; Chenming Zhang
Journal:  Biomaterials       Date:  2017-05-19       Impact factor: 12.479

2.  Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density.

Authors:  Zongmin Zhao; Kristen Powers; Yun Hu; Michael Raleigh; Paul Pentel; Chenming Zhang
Journal:  Biomaterials       Date:  2017-01-27       Impact factor: 12.479

3.  Nicotinic Acetylcholine Receptors as Targets for Tobacco Cessation Therapeutics: Cutting-Edge Methodologies to Understand Receptor Assembly and Trafficking.

Authors:  Ashley M Fox-Loe; Linda P Dwoskin; Christopher I Richards
Journal:  Neuromethods       Date:  2016-09-30

4.  r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.

Authors:  Joshua S Beckmann; Andrew C Meyer; M Pivavarchyk; David B Horton; Guangrong Zheng; Andrew M Smith; Thomas E Wooters; J Michael McIntosh; Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Neurochem Res       Date:  2015-07-31       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.